Sign up to save your podcasts
Or
Share NRG-GU006 at the 2025 ASTRO Clinical Trials Session
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
NRG-GU006 at the 2025 ASTRO Clinical Trials Session
Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.
View all episodes
By NRG Oncology
5
1010 ratings
Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.
More shows like The NRG Oncology Podcast
View all
The Joe Rogan Experience
230,094 Listeners
The New Yorker Radio Hour
6,815 Listeners
Planet Money
30,725 Listeners
Marketplace
8,789 Listeners
Investing Insights
531 Listeners
Fantasy Footballers - Fantasy Football Podcast
29,469 Listeners
White Coat Investor Podcast
2,457 Listeners
The Daily
112,945 Listeners
The Indicator from Planet Money
9,558 Listeners
QuadShot News Podcast
63 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
10,239 Listeners
The Ezra Klein Show
16,338 Listeners
Plain English with Derek Thompson
2,181 Listeners
At The Beam
37 Listeners
Value Health Voices
5 Listeners